位置:首页 > 产品库 > 重组Ig和ITIM域蛋白T-细胞免疫受体(TIGIT)
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
重组Ig和ITIM域蛋白T-细胞免疫受体(TIGIT)
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。

重组Ig和ITIM域蛋白T-细胞免疫受体(TIGIT)真核蛋白
Recombinant TIGIT
基因名:

TIGIT


产品别名:

VSIG9; VSTM3; WUCAM; TIGIT; T cell immunoreceptor with Ig and ITIM domains; T cell immunoreceptor with Ig and ITIM domains; T-cell immunoreceptor with Ig and ITIM domains; V-set and immunoglobulin domain containing 9; V-set and immunoglobulin domain-containing protein 9; V-set and transmembrane domain containing 3; V-set and transmembrane domain-containing protein 3; VSIG9, VSTM3; Washington University cell adhesion molecule; Ig和ITIM域蛋白T-细胞免疫受体(TIGIT); Ig和ITIM域蛋白T-细胞免疫受体(TIGIT)真核蛋白; TIGIT蛋白;


背景信息:
T cell immunoreceptor with Ig and ITIM domains (TIGIT) is a member of the CD28 family within the Ig superfamily of proteins. TIGIT is expressed on NK cells and subsets of activated, memory and regulatory T cells, and particularly on follicular helper T cells within secondary lymphoid organs. It binds to CD155 and Nectin-2 that appear on dendritic cells (DC) and endothelium. Ligation of TIGIT on T cells down-regulates TCR-mediated activation and subsequent proliferation, while NK cell TIGIT ligation blocks NK cell cytotoxicity. Through CD155 and Nectin-2, which also interact with DNAM-1/CD226 and CD96/Tactile, TIGIT is part of an interacting network of Ig superfamily members that may augment or oppose each other. In particular, TIGIT binding to CD155 can antagonize the effects of DNAM1.
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025